CN104547876A - Traditional Chinese medicine for treating hepatitis B - Google Patents
Traditional Chinese medicine for treating hepatitis B Download PDFInfo
- Publication number
- CN104547876A CN104547876A CN201310482191.5A CN201310482191A CN104547876A CN 104547876 A CN104547876 A CN 104547876A CN 201310482191 A CN201310482191 A CN 201310482191A CN 104547876 A CN104547876 A CN 104547876A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to traditional Chinese medicine for treating hepatitis B. The adopted preparation scheme lies in that the traditional Chinese medicine is prepared from the following Chinese medicinal materials in parts by weight: 15 parts of radix bupleuri, 15 parts of radix scutellariae, 15 parts of coptis chinensis, 13 parts of salvia miltiorrhiza, 13 parts of radix paeoniae alba, 13 parts of cinnamomum cassia, 13 parts of dendrobium crepidatum, 15 parts of angelica sinensis, 15 parts of radices trichosanthis, 15 parts of rhizoma atractylodis, 20 parts of mulberry fruit, 20 parts of radix aucklandiae, 20 parts of fructus aurantii, 20 parts of radix curcumae, 20 parts of herba artemisiae scopariae, 13 parts of radix liquiritiae, 13 parts of radix paeoniae rubrathe and 13 parts of pericarpium citri reticulatae. The traditional Chinese medicine has the benefits that the preparation is prepared from pure Chinese medicinal herbs, is high in curative effect for hepatitis B, treats both symptoms and root causes, is significant in curative effect, has no adverse reaction, and is little in toxic and side effects; clinical symptoms disappear quickly, and no resurgence phenomenon exists after hepatitis B is cured.
Description
Technical field
The present invention relates to a kind of Chinese medicine, especially for a kind of Chinese medicine for the treatment of B-type hepatitis.
Technical background
B-type hepatitis is one of disease being difficult in the world cure.Because hepatitis B virus infectiousness is strong, sickness rate is high, cure rate is low, and is difficult to eradicate.Up to now, clinical its curative effect of Chinese and Western medicine used is all undesirable, becomes a great problem of medical circle.
Summary of the invention
The invention provides a kind of effective, instant effect, have Be very effective, drug effect is definite, a kind of Chinese medicine for the treatment of B-type hepatitis of quick result.
The technology of the present invention problem is realized by following scheme:
Treat a Chinese medicine for B-type hepatitis, adopt following Chinese medicine proportioning production program: Radix Bupleuri 10-20 parts, Radix Scutellariae 10-20 parts, Rhizoma Coptidis 10-20 parts, Radix Salviae Miltiorrhizae 10-15 parts, the Radix Paeoniae Alba 10-15 parts, tree 10-15 parts, osmanthus, Radix Et Rhizoma Rhei 10-15 parts, Radix Angelicae Sinensis 10-20 parts, Radix Trichosanthis 10-20 parts, Rhizoma Atractylodis 10-25 parts, Fructus Mori 15-25 parts, the Radix Aucklandiae 10-25 parts, Fructus Aurantii 10-25 parts, Radix Curcumae 10-25 parts, Artemisia anethoicles Mattf 10-25 parts, 10-15 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 10-15 parts, Pericarpium Citri Reticulatae 10-15 parts.
During treatment, take the crude drug in formula, add suitable quantity of water, after slow fire boiling about 40 minute hand, elimination medicinal residues, make decoction, oral, every mouthful of potion, serve on 5 doses, and 5 doses is a course for the treatment of, serve on 3-4 courses for the treatment of.
Good effect of the present invention is that preparation is that pure Chinese herbal medicine is made, and the curative effect for B-type hepatitis is higher, and treating both the principal and secondary aspects of a disease is evident in efficacy, has no adverse reaction, toxic and side effects is little, and clinical symptom disappearance is rapid, without rebound phenomena after curing.
Detailed description of the invention
Embodiment one
Treat a Chinese medicine for B-type hepatitis, adopt following Chinese medicine proportioning production program: Radix Bupleuri 15 parts, Radix Scutellariae 15 parts, Rhizoma Coptidis 15 parts, Radix Salviae Miltiorrhizae 13 parts, the Radix Paeoniae Alba 13 parts, tree 13 parts, osmanthus, Radix Et Rhizoma Rhei 13 parts, Radix Angelicae Sinensis 15 parts, Radix Trichosanthis 15 parts, Rhizoma Atractylodis 15 parts, Fructus Mori 20 parts, the Radix Aucklandiae 20 parts, Fructus Aurantii 20 parts, Radix Curcumae 20 parts, Artemisia anethoicles Mattf 20 parts, 13 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 13 parts, Pericarpium Citri Reticulatae 13 parts.
Embodiment two
Treat a Chinese medicine for B-type hepatitis, by weight Radix Bupleuri 20 parts, Radix Scutellariae 20 parts, Rhizoma Coptidis 20 parts, Radix Salviae Miltiorrhizae 15 parts, the Radix Paeoniae Alba 15 parts, tree 15 parts, osmanthus, Radix Et Rhizoma Rhei 15 parts, Radix Angelicae Sinensis 20 parts, Radix Trichosanthis 20 parts, Rhizoma Atractylodis 25 parts, Fructus Mori 25 parts, the Radix Aucklandiae 25 parts, Fructus Aurantii 25 parts, Radix Curcumae 25 parts, Artemisia anethoicles Mattf 25 parts, 15 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 15 parts, Pericarpium Citri Reticulatae 15 parts.
Embodiment three
Treat a Chinese medicine for B-type hepatitis, by weight Radix Bupleuri 10 parts, Radix Scutellariae 10 parts, Rhizoma Coptidis 10 parts, Radix Salviae Miltiorrhizae 10 parts, the Radix Paeoniae Alba 10 parts, tree 10 parts, osmanthus, Radix Et Rhizoma Rhei 10 parts, Radix Angelicae Sinensis 10 parts, Radix Trichosanthis 10 parts, Rhizoma Atractylodis 10 parts, Fructus Mori 15 parts, the Radix Aucklandiae 10 parts, Fructus Aurantii 10 parts, Radix Curcumae 10 parts, Artemisia anethoicles Mattf 10 parts, 10 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 10 parts, Pericarpium Citri Reticulatae 10 parts.
Claims (4)
1. treat a Chinese medicine for B-type hepatitis, it is characterized in that adopting following Chinese medicine proportioning production program: Radix Bupleuri 10-20 parts, Radix Scutellariae 10-20 parts, Rhizoma Coptidis 10-20 parts, Radix Salviae Miltiorrhizae 10-15 parts, the Radix Paeoniae Alba 10-15 parts, tree 10-15 parts, osmanthus, Radix Et Rhizoma Rhei 10-15 parts, Radix Angelicae Sinensis 10-20 parts, Radix Trichosanthis 10-20 parts, Rhizoma Atractylodis 10-25 parts, Fructus Mori 15-25 parts, the Radix Aucklandiae 10-25 parts, Fructus Aurantii 10-25 parts, Radix Curcumae 10-25 parts, Artemisia anethoicles Mattf 10-25 parts, 10-15 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 10-15 parts, Pericarpium Citri Reticulatae 10-15 parts.
2. a kind of Chinese medicine for the treatment of B-type hepatitis according to claim 1, is characterized in that Radix Bupleuri 15 parts, Radix Scutellariae 15 parts, Rhizoma Coptidis 15 parts, Radix Salviae Miltiorrhizae 13 parts, the Radix Paeoniae Alba 13 parts, tree 13 parts, osmanthus, Radix Et Rhizoma Rhei 13 parts, Radix Angelicae Sinensis 15 parts, Radix Trichosanthis 15 parts, Rhizoma Atractylodis 15 parts, Fructus Mori 20 parts, the Radix Aucklandiae 20 parts, Fructus Aurantii 20 parts, Radix Curcumae 20 parts, Artemisia anethoicles Mattf 20 parts, 13 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 13 parts, Pericarpium Citri Reticulatae 13 parts by weight.
3. a kind of Chinese medicine for the treatment of B-type hepatitis according to claim 1, is characterized in that Radix Bupleuri 20 parts, Radix Scutellariae 20 parts, Rhizoma Coptidis 20 parts, Radix Salviae Miltiorrhizae 15 parts, the Radix Paeoniae Alba 15 parts, tree 15 parts, osmanthus, Radix Et Rhizoma Rhei 15 parts, Radix Angelicae Sinensis 20 parts, Radix Trichosanthis 20 parts, Rhizoma Atractylodis 25 parts, Fructus Mori 25 parts, the Radix Aucklandiae 25 parts, Fructus Aurantii 25 parts, Radix Curcumae 25 parts, Artemisia anethoicles Mattf 25 parts, 15 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 15 parts, Pericarpium Citri Reticulatae 15 parts by weight.
4. a kind of Chinese medicine for the treatment of B-type hepatitis according to claim 1, is characterized in that Radix Bupleuri 10 parts, Radix Scutellariae 10 parts, Rhizoma Coptidis 10 parts, Radix Salviae Miltiorrhizae 10 parts, the Radix Paeoniae Alba 10 parts, tree 10 parts, osmanthus, Radix Et Rhizoma Rhei 10 parts, Radix Angelicae Sinensis 10 parts, Radix Trichosanthis 10 parts, Rhizoma Atractylodis 10 parts, Fructus Mori 15 parts, the Radix Aucklandiae 10 parts, Fructus Aurantii 10 parts, Radix Curcumae 10 parts, Artemisia anethoicles Mattf 10 parts, 10 parts, Radix Glycyrrhizae, Radix Paeoniae Rubra 10 parts, Pericarpium Citri Reticulatae 10 parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310482191.5A CN104547876A (en) | 2013-10-16 | 2013-10-16 | Traditional Chinese medicine for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310482191.5A CN104547876A (en) | 2013-10-16 | 2013-10-16 | Traditional Chinese medicine for treating hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104547876A true CN104547876A (en) | 2015-04-29 |
Family
ID=53065647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310482191.5A Pending CN104547876A (en) | 2013-10-16 | 2013-10-16 | Traditional Chinese medicine for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104547876A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106389655A (en) * | 2016-11-22 | 2017-02-15 | 广西大学 | Drug for treating HepatitisBHBeAg of HBV (hepatitis B virus) and preparation method of drug |
| CN106492130A (en) * | 2016-12-15 | 2017-03-15 | 钦州市钦南区科学技术情报研究所 | A kind of treat Chinese medicine of B-type hepatitis and preparation method thereof |
-
2013
- 2013-10-16 CN CN201310482191.5A patent/CN104547876A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106389655A (en) * | 2016-11-22 | 2017-02-15 | 广西大学 | Drug for treating HepatitisBHBeAg of HBV (hepatitis B virus) and preparation method of drug |
| CN106492130A (en) * | 2016-12-15 | 2017-03-15 | 钦州市钦南区科学技术情报研究所 | A kind of treat Chinese medicine of B-type hepatitis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104547876A (en) | Traditional Chinese medicine for treating hepatitis B | |
| CN105641391A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN104666627A (en) | Traditional Chinese medicine for treatment of liver diseases | |
| CN104547628A (en) | Traditional Chinese medicine for treating migraine | |
| CN102309600A (en) | Traditional Chinese medicine prescription for treating acne rosacea | |
| CN105617236A (en) | Traditional Chinese medicine for treating hepatitis B and preparation method thereof | |
| CN104547881A (en) | Traditional Chinese medicine for reducing blood lipids | |
| CN104721724A (en) | Traditional Chinese medicine for treating viral hepatitis B and preparation method thereof | |
| CN105664010A (en) | Traditional Chinese medicine for treating hepatitis B and preparation method of traditional Chinese medicine | |
| CN104666948A (en) | Traditional Chinese medicine for treating hypertension | |
| CN104189727A (en) | Traditional Chinese medicine used for treating intermenstrual sentiment abnormality | |
| CN105617036A (en) | Traditional Chinese medicine preparation for treating cardiovascular disease and production method thereof | |
| CN103394023A (en) | Traditional Chinese medicine used for treating viral hepatitis A | |
| CN103041018A (en) | Migraine treatment method using Chinese medicaments | |
| CN104721450A (en) | Traditional Chinese medicine for treating abnormal menstruation and preparation method thereof | |
| CN105617235A (en) | Traditional Chinese medicine for treating acute pancreatitis and preparation method thereof | |
| CN105535554A (en) | Cardiovascular treating traditional Chinese medicine | |
| CN103566327A (en) | Asthma-relieving decoction and preparation method thereof | |
| CN104547315A (en) | Traditional Chinese medicine for treating dysmenorrheal | |
| CN104547218A (en) | Traditional Chinese medicine for treating colitis | |
| CN102370841A (en) | Chinese herbal prescription for treating stagnation of qi due to depression of liver in later menstrual period | |
| CN104547254A (en) | Traditional Chinese medicine for treating hypertension | |
| CN105617187A (en) | Traditional Chinese medicine for treating chronic gastritis | |
| CN104547316A (en) | Traditional Chinese medicine for treating eye diseases | |
| CN104547330A (en) | Traditional Chinese medicine for treating cerebral thrombosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150429 |